Our Deep Expertise

Specialized knowledge spanning the entire drug development continuum, from molecule design to commercial market access.

Decades of combined experience delivering transformative therapies across preclinical, clinical, advanced therapies, and biopharmaceutical domains.


Six Core Areas of Excellence

Integrated capabilities covering the complete research and development lifecycle

Preclinical Studies

Early-stage research excellence through laboratory and animal testing, ensuring rigorous evaluation of safety, efficacy, and pharmacological properties before advancing to human trials.

Clinical Studies

Full-spectrum clinical trial expertise managing studies of all phases and complexities with global regulatory compliance and operational excellence from feasibility through final submission.

Stem Cell & Gene Therapy

Advanced therapy innovation with specialized infrastructure and expert teams navigating the complex regulatory landscape of cutting-edge cell and gene therapies.

Biopharmaceuticals: Commercial & Manufacturing

End-to-end vaccine and biotherapeutic development with WHO-prequalified manufacturing, ensuring life-saving products reach global markets safely and efficiently.

Pharmacovigilance

Comprehensive drug safety monitoring and risk management throughout the product lifecycle, ensuring patient safety and regulatory compliance across all markets.

Medical Affairs

Strategic medical leadership bridging science and healthcare through scientific liaison, clinical education, and real-world evidence integration for optimal patient outcomes.


Preclinical Studies Excellence

Accelerating Discovery. Advancing Therapies.

Preclinical trials are essential early-stage studies to evaluate the safety, efficacy, and pharmacological properties of new drug candidates before clinical trials in humans. They involve laboratory and animal testing, including in vitro and in vivo studies, pharmacokinetics, and toxicology.

Provaxa, through its collaborative vendor alliance, provides expertise, advanced technology, and regulatory support, helping pharmaceutical companies generate reliable data, reduce costs, and speed up development. This phase ensures drugs meet compliance standards and are ready for clinical testing.

Key Services Include:

  • In vitro and in vivo studies to evaluate drug safety and efficacy
  • Pharmacokinetics and pharmacodynamics analysis to understand drug behaviour in the body
  • Drug formulation development and optimization for improved delivery and stability
  • Toxicology testing to assess potential risks and side effects
  • Regulatory support, including preparation of documentation for compliance with Good Laboratory Practice (GLP) standards
Preclinical Studies - Laboratory Research

Clinical Studies Services

Driving Research, Delivering Results

From feasibility to final submission, our experts manage studies of all scales and complexities. We work with global sponsors, regional hospitals, and regulatory bodies to ensure studies are executed to the highest international standards adhering to ICH-GCP guidelines.

Our comprehensive clinical trial management spans therapeutic areas including metabolic disorders, respiratory, oncology, cardiovascular, ophthalmology, dermatology, rheumatology, and many others, with specialized expertise in complex and rare disease indications.

Key Services Include:

  • Feasibility & site selection
  • Regulatory submissions & ethics approvals
  • Monitoring, data management, and biostatistics
  • Quality oversight & audit readiness
  • eCOA (electronic Clinical Outcome Assessment) implementation for patient-reported outcomes
Clinical Studies - Patient Trial Management

Stem Cell & Gene Therapy Excellence

Powering Life Through Genetic Innovation

Stem Cell and Gene therapies represent a revolutionary frontier in modern medicine, offering the potential to treat and even cure conditions that were once deemed untreatable. These therapies work by modifying or replacing a patient's Stem Cells or Genetic material to restore normal function or fight disease.

At the forefront of innovation, Stem Cell and Gene therapy clinical studies are designed to evaluate the safety and effectiveness of these advanced treatments. Given the personalized and complex nature of these therapies, clinical studies often involve specialized protocols, precise biomarker assessments, and rapid data turnaround to ensure patient safety and optimal outcomes.

Oncology remains the primary focus, with many studies targeting cancers through Gene-modified Stem Cell therapies like CAR T-Stem Cell treatments, but research also spans autoimmune diseases, infectious diseases, and rare Genetic disorders.

Key Services Include:

  • ATMP clinical study design & execution
  • GMP-compliant processing & logistics
  • Patient recruitment & long-term follow-up
  • Global regulatory alignment and compliance
Stem Cell & Gene Therapy - Advanced Treatment

Biopharmaceuticals: Commercial & Manufacturing Excellence

From research to real-world care, delivering WHO-prequalified vaccines and therapies

Provaxa is at the forefront of global healthcare innovation, pioneering vaccines and biotherapeutics that are transforming lives worldwide. Our relentless pursuit of scientific breakthroughs is driven by a deep commitment to solving urgent medical challenges and shaping the future of medicine.

With cutting-edge research and breakthrough technologies, we have developed vaccines that are redefining public health standards and offering hope to millions. Integrity guides every step, from data accuracy to patient safety, ensuring our work inspires trust and lasting impact.

Present in over 50 countries, Provaxa is dedicated to making life-saving treatments accessible and affordable for all. Powered by an enthusiastic team of experts, we combine visionary science with compassionate care to build healthier, stronger communities around the globe.

Key Services Include:

  • R&D and process development
  • GMP manufacturing for clinical and commercial supply
  • Stability studies & quality control testing
  • Technology transfer & scale-up
Biopharmaceuticals - Manufacturing & Production

Pharmacovigilance Excellence

Guarding Health Through Vigilance

Pharmacovigilance in clinical research and trials is the science and practice of ensuring drug and patient safety by systematically monitoring, detecting, assessing, and preventing adverse effects or any other drug-related problems throughout a product's lifecycle, beginning in clinical development and continuing post-approval.

Pharmacovigilance is integral to identifying, evaluating, and managing risks during clinical trials, facilitating early detection of adverse drug reactions (ADRs), and ensuring the balance of benefit versus risk is continually reassessed as new safety data emerges.

Our comprehensive pharmacovigilance services are designed to support pharmaceutical companies in maintaining compliance and enhancing drug safety throughout the product lifecycle. Robust pharmacovigilance systems ensure high standards of patient safety within trials, support regulatory approval, and provide the scientific basis for product labeling, risk management, and post-marketing surveillance.

Key Services Include:

  • Adverse Event (AE) and Serious Adverse Event (SAE) Reporting
  • Signal Detection and Risk Management
  • Case Processing and Literature Screening
  • Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs)
  • Pharmacovigilance System Master File (PSMF) Maintenance
  • Regulatory Compliance and Audits
Pharmacovigilance - Safety Monitoring

Medical Affairs Excellence

Driving Clinical Excellence Through Medical Expertise

At Provaxa, we understand how this function plays a vital role in building strong relationships with key opinion leaders, facilitating medical education, and integrating real-world evidence to optimize patient outcomes and regulatory compliance.

Medical Affairs is a cornerstone of clinical research and trials, providing scientific, regulatory, and operational expertise that ensures the quality, integrity, and patient-centricity of studies from protocol design through publication and lifecycle management.

Medical Affairs teams bridge science, healthcare, and business by guiding protocol development, supporting regulatory submissions, offering safety oversight, and engaging with investigators and patients.

Key Services Include:

  • Scientific consulting for protocol development and trial design
  • Medical and scientific support for regulatory submissions and meetings
  • Board-certified medical monitoring and safety oversight
  • Identification and engagement of trial sites and key opinion leaders
  • Real-world evidence generation and patient advocacy support
  • Support for publication planning and scientific communications
Medical Affairs - Clinical Engagement & Expertise

Leverage Our Comprehensive Expertise

Partner with Provaxa to access deep, specialized knowledge across the entire drug development spectrum.